Antisense Therapeutics Ltd banner

Antisense Therapeutics Ltd
F:AWY

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
F:AWY
Watchlist
Price: 0.046 EUR -0.86% Market Closed
Market Cap: €41.5m

Wall St Price Targets

AWY Price Targets Summary
Antisense Therapeutics Ltd

There are no price targets for AWY.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Antisense Therapeutics Ltd Competitors:
Price Targets
EVER
EverQuote Inc
1% Upside

Revenue
Forecast

-25% / Year
Past Growth
107% / Year
Estimated Growth
Estimates Accuracy
-98%
Average Miss
-25% / Year
Past Growth
107% / Year
Estimated Growth
Estimates Accuracy
-98%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -25%. The projected CAGR for the next 3 years is 107%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Antisense Therapeutics Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Antisense Therapeutics Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AWY's stock price target?
Not Available

AWY does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Antisense Therapeutics Ltd?
Projected CAGR
107%

Over the last 8 years, the compound annual growth rate for Revenue has been -25%. The projected CAGR for the next 3 years is 107%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett